Q2 2023 Holdings
Filed 2023-08-14 | 57 holdings | $302.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $25.0M | 300,000 | 8.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $20.5M | 825,000 | 6.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $16.8M | 330,000 | 5.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $16.8M | 360,000 | 5.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $16.4M | 180,000 | 5.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $14.0M | 280,000 | 4.6% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $13.3M | 525,000 | 4.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $12.7M | 55,000 | 4.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $11.9M | 550,000 | 3.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $10.5M | 650,000 | 3.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.7M | 85,000 | 3.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $8.9M | 100,000 | 2.9% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $8.7M | 85,000 | 2.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.9M | 110,000 | 2.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.3M | 350,000 | 2.4% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $7.2M | 200,000 | 2.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.1M | 185,000 | 2.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.8M | 575,000 | 2.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.2M | 225,000 | 2.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.7M | 240,000 | 1.9% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $4.2M | 190,000 | 1.4% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.0M | 65,000 | 1.3% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $4.0M | 22,500 | 1.3% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $3.9M | 238,225 | 1.3% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $3.7M | 150,000 | 1.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $3.6M | 347,432 | 1.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $3.5M | 201,197 | 1.1% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $2.8M | 100,000 | 0.9% |
| Karuna Therapeutics Inc | COM | 48576A100 | $2.7M | 12,500 | 0.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $2.7M | 150,000 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.5M | 200,000 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.5M | 300,173 | 0.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.5M | 215,000 | 0.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $2.3M | 20,000 | 0.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $2.3M | 110,000 | 0.8% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $2.2M | 154,250 | 0.7% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $1.9M | 412,699 | 0.6% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $1.9M | 100,000 | 0.6% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $1.8M | 280,981 | 0.6% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $1.7M | 250,000 | 0.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $1.5M | 75,000 | 0.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $1.5M | 75,000 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.4M | 200,000 | 0.5% |
| Morphic Hldg Inc | COM | 61775R105 | $1.1M | 20,000 | 0.4% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $908.6K | 35,000 | 0.3% |
| Bioxcel Therapeutics Inc(BTAIEUR)Call | COM | 09075P105 | $865.8K | 130,000 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $723.1K | 27,578 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $722.4K | 42,000 | 0.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $720.9K | 65,000 | 0.2% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $704.0K | 100,000 | 0.2% |